Abstract:Innate immune receptor TLR4 plays an important role in glycolipid metabolism. The objective of this study is to investigate the inhibitory effects of blocking TLR4 on hyperglycemia and hyperlipidemia by comparing WT and TLR4−/− mice in obesity and diabetes modeling. The knockout of the TLR4 gene could prevent weight gain induced by a high-fat diet (HFD)/high-sugar and high-fat diet (HSHFD), and the differences in the responses existed between the sexes. It extends the time required to reach the obesity criteria. However, when mice were injected with intraperitoneal streptozotocin (STZ) after being fed by HSHFD for two months, TLR4−/− mice exhibited less weight loss than WT. Blocking TLR4 alleviated the changes in body weight and blood glucose, consequently reducing the efficiency of diabetes modeling, especially for male mice. Additionally, male TLR4−/− obese mice exhibit lower total cholesterol (TC) and low-density lipoprotein (LDL) levels in serum and less formation of fat droplets in the liver compared to WT. On the other hand, the knockout of TLR4 significantly increased the high-density lipoprotein (HDL) of male mice. This study should provide new insights into the role of TLR4, as well as opportunities to target novel approaches to the prevention and treatment of metabolic diseases like obesity and diabetes.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the inhibitory effect of blocking Toll - like receptor 4 (TLR4) on hyperglycemia and hyperlipidemia, and to reveal the role of TLR4 in glucose and lipid metabolism by comparing the performance of wild - type (WT) and TLR4 gene - knockout (TLR4−/−) mice in obesity and diabetes models. Specifically, the study aims to answer the following questions: 1. **What is the specific role of TLR4 in glucose and lipid metabolism?** - TLR4, as an innate immune recognition molecule, has been recently found to be involved in the regulation of glucose and lipid metabolism. However, its specific mechanism is still unclear. 2. **What are the effects of TLR4 gene knockout on the body weight, blood glucose and blood lipid of mice in obesity and diabetes models?** - The study established obesity and diabetes models by feeding a high - fat diet (HFD) or a high - sugar and high - fat diet (HSHFD) and combined with streptozotocin (STZ) injection, and observed the differences between TLR4−/− mice and WT mice. 3. **How does gender difference affect the effect of TLR4 gene knockout?** - The study also explored the influence of gender difference on the effect of TLR4 gene knockout, especially the different responses of male and female mice in body weight change, blood glucose and blood lipid levels. 4. **Can TLR4 be a new target for the prevention and treatment of metabolic diseases?** - Through the above experimental results, the study attempts to provide new insights into TLR4 as a potential treatment target for metabolic diseases, especially in the prevention and treatment of obesity and diabetes. ### Main conclusions - **Body weight change**: TLR4 gene knockout significantly reduced the body weight gain caused by high - fat diet in male mice, while having a smaller impact on female mice. - **Blood glucose control**: TLR4 gene knockout decreased the blood glucose level in male mice and reduced the success rate of the diabetes model, especially in male mice. - **Blood lipid level**: The total cholesterol (TC) and low - density lipoprotein (LDL) levels in male TLR4−/− obese mice were lower, and the formation of intrahepatic lipid droplets was reduced; at the same time, the high - density lipoprotein (HDL) level was significantly increased. - **Gender difference**: Male mice had a more obvious response to TLR4 gene knockout, showing greater changes in body weight, blood glucose and blood lipid. These results indicate that TLR4 plays an important role in glucose and lipid metabolism and may become a new target for the prevention and treatment of obesity and diabetes.

Inhibition of Hyperglycemia and Hyperlipidemia by Blocking Toll-like Receptor 4: Comparison of Wild-Type and Toll-like Receptor 4 Gene Knockout Mice on Obesity and Diabetes Modeling

Abrogation of Toll-Like Receptor 4 Mitigates Obesity-Induced Oxidative Stress, Proinflammation, and Insulin Resistance Through Metabolic Reprogramming of Mitochondria in Adipose Tissue

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet

Hepatocyte Toll-like Receptor 4 Regulates Obesity-Induced Inflammation and Insulin Resistance.

Abstract 15583: Toll-Like Receptor 4 Knockout Preserves Cardiac Function in High Fat Diet-Induced Obesity

TLR4/AP-1-Targeted Anti-Inflammatory Intervention Attenuates Insulin Sensitivity and Liver Steatosis

Toll-like receptor 3 ablation prevented high-fat diet-induced obesity and metabolic disorder

Chronic low-grade inflammation is involved in TLR4 knockout-induced spontaneous obesity in aged mice

Beyond Knockout: A Novel Homodimerization-Targeting MyD88 Inhibitor Prevents and Cures Type 1 Diabetes in NOD Mice

Luteolin Targets the Toll-Like Receptor Signaling Pathway in Prevention of Hepatic and Adipocyte Fibrosis and Insulin Resistance in Diet-Induced Obese Mice

Liver-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice

Impaired adipose expansion caused by liver X receptor activation is associated with insulin resistance in mice fed a high-fat diet.

Adipocyte LDL receptor–related protein–1 expression modulates postprandial lipid transport and glucose homeostasis in mice

Improvement of Adipose Macrophage Polarization in High Fat Diet-Induced Obese GHSR Knockout Mice

2047-LB: METTL2 Knockout Mitigates Obesity and Metabolic Disorders Induced by High-Fat Diet

Knockdown of IL4I1 Improved High Glucose-evoked Insulin Resistance in HepG2 Cells by Alleviating Inflammation and Lipotoxicity Through AHR Activation

Microglia/macrophage-specific deletion of TLR-4 protects against neural effects of diet-induced obesity

High fat diet induced obesity model using four strains of mice: Kunming, C57BL/6, BALB/c and ICR

TLR4 inhibition ameliorated glucolipotoxicity-induced differentiation suppression in osteoblasts via RIAM regulation of NF-κB nuclear translocation

Targeting inhibition of CCR5 on improving obesity-associated insulin resistance and impairment of pancreatic insulin secretion in high fat-fed rodent models

Toll-like receptor 4 deletion partially protects mice from high fat diet-induced arterial stiffness despite perturbation to the gut microbiota